LONDON (Reuters) - Airbus CEO Guillaume Faury said he could see the two separate European programmes working on new fighter ...
Plug Power Inc. (NASDAQ:PLUG) shares rose 3.4% in pre-open trading Wednesday following the announcement of a significant ...
The co-chair of Trump's transition effort and the longtime chief executive of financial services firm Cantor Fitzgerald, ...
While the FTSE 100 has rallied by 92 points, or 1.1%, on the back of relieving inflation data on both sides of the Atlantic, ...
Spot gold rose 0.1% to $2,6675.90 an ounce, while gold futures expiring in February rose 0.3% to $2,690.91 an ounce by 23:59 ET (04:49 GMT). Markets were now focused squarely on upcoming consumer ...
WASHINGTON (Reuters) -President-elect Donald Trump's pick to lead the Pentagon, Pete Hegseth, endured fierce Democratic ...
Livium Ltd (ASX:LIT, OTC:LMMFF) has signed an exclusive agreement to provide recycling services for lithium-ion batteries ...
Going forward, Hays said it is closely monitoring early-year trends in temporary recruitment, traditionally a critical period for this segment. According to the company, the slowdown in permanent ...
Traders were also awaiting an interest rate decision in China and labor market data from Australia- due in the coming days- ...
周三,知名研究公司CFRA将花旗 (NYSE:C)股票的目标价从83.00美元上调至90.00美元。该公司分析师Kenneth Leon维持对该银行股票的买入评级。Leon更新后的目标价基于12.0倍的远期市盈率 ...
周三,伯恩斯坦分析师维持了对礼来股票 (NYSE:LLY)的积极立场,重申了"优于大市"评级和1,100.00美元的目标价。这家制药巨头公布了2024年的收入预期和2025年的指引,显示第四季度GLP-1收入低于市场一致预期。
礼来本周在旧金山的一次会议上讨论了2025年的预测,花旗分析师注意到该公司预期收入增长中位数为32%。这一预测被视为强劲的替雷利肽需求、随着可及性提高而进一步增长的潜力、美国以外的机会以及礼来在增incretin疗法之外的产品组合表现强劲的反映。